Skip to content

Retrospective clinical study for comparison of survival between high albumin leakage and low albumin leakage in super high-flux hemodialysis

Retrospective clinical study for comparison of survival between high albumin leakage and low albumin leakage in super high-flux hemodialysis with beta2-microglobulin clearance over 70 mL/min - Prognosis verification of albumin leakage in SHF-HD with beta2-microglobulin clearance over 70 mL/min

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050068
Enrollment
300
Registered
2023-03-01
Start date
2023-01-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with end-stage kidney disease undergoing hemodialysis

Interventions

None listed

Sponsors

others
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients on maintenance hemodialysis as of July 1, 2017

Exclusion criteria

Exclusion criteria: 1) Under 20 years of age 2) Dialysis conditions (dialysis method, membrane material) between April 1, 2017 and June 30, 2017, which are different from those as of July 1, 2017 3) Blood purification methods other than HD 4) Dialysis frequency below 3 sessions per week or dialysis time below 3 hour per session 5) Use of dialyzers with beta2-microgloburln clearance below 70 mL/min and Type S 6) Pregnant or lactating patients 7) Missing data for covariates at study entry

Design outcomes

Primary

MeasureTime frame
3-year all-cause mortality

Countries

Japan

Contacts

Public ContactManabu Tashiro

Social medical corporation Kawashimakai Kawashima Hospital Department of Nephrology

m.tashiro@khg.or.jp088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026